Advertisement
News
Subscribe to MDT Magazine News

Osiris Therapeutics posts smaller 4Q profit

March 7, 2011 6:45 am | by The Associated Press | Comments

Osiris Therapeutics reported Monday that net income dropped 72 percent in the fourth quarter compared with a year ago, when the stem cell therapy developer received a payment from the sale of its Osteocel business.The company beat most Wall Street estimates, according to analyst polled by...

AACR 102nd Annual Meeting Press Conference Schedule

March 7, 2011 6:32 am | by AACR | Comments

Tweet ORLANDO, Fla. - The American Association for Cancer Research will hold its 102nd Annual Meeting at the Orange County Convention Center from April 2-6, 2011. More than 18,000 people will gather to hear the latest innovations in basic, translational and clinical research. The AACR...

TOPICS:

Accuray agrees to buy TomoTherapy for $277M

March 7, 2011 5:45 am | by The Associated Press | Comments

Accuray Inc. said Monday it will buy TomoTherapy Inc. for $277 million in a deal that unites two companies that make radiation therapy systems.Accuray said it will acquire TomoTherapy for $4.80 per share in cash and stock, which is a 30.8 percent premium to the most recent closing price of...

Advertisement

Hold your breath: Air pollution plays role in cardiac, metabolic diseases

March 7, 2011 5:33 am | by EurekAlert | Comments

(Michigan State University) To explore one of the most critical health/environment intersections -- how the very air we breathe can cause heart disease and diabetes and contribute to the problems of obesity -- Michigan State University has been named a Clean Air Research Center by the...

TOPICS:

Allied Healthcare buys Scottish homecare business

March 7, 2011 4:45 am | by The Associated Press | Comments

British health care staffing company Allied Healthcare International Inc. said Monday it acquired a Scottish business which provides health care in a patient's home. The deal was valued at 2.5 million pounds ($4.1 million).Allied said it bought ScotHomecare, which was part of Health and...

Michael Petras, Former CEO of GE Lighting, Named CEO of Cleveland-Based Specialty Medical Supplies Leader

March 7, 2011 4:35 am | by Bio-Medicine.Org | Comments

CLEVELAND, March 7, 2011 /- HGI Global Holdings, Inc., a leading provider of specialty medical products to chronic disease patients, today announced the appointment of Michael B. Petras, Jr. as Chief Executive Officer, effective March 21. Mr. Petras, 43, joins HGI from GE Lighting, the...

TOPICS:

Uroplasty to Present at ROTH Capital Partners 23rd Annual OC Growth Stock Conference

March 7, 2011 4:34 am | by Bio-Medicine.Org | Comments

MINNEAPOLIS, March 7, 2011 /- Uroplasty, Inc. (Nasdaq: UPI ), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, announced today that it will be presenting at the ROTH Capital Partners 23rd Annual OC Growth Stock...

TOPICS:

Boston Scientific Announces European Approval and Launch of OMEGAâ„¢ Platinum Chromium Stent System

March 7, 2011 4:34 am | by Bio-Medicine.Org | Comments

NATICK, Mass., March 7, 2011 /- Boston Scientific Corporation (NYSE: BSX ) today announced it has received CE Mark for its OMEGA™ Platinum Chromium Bare-Metal Coronary Stent System, the Company's third-generation coronary stenting technology.  It incorporates Boston...

TOPICS:
Advertisement

Isis Pharmaceuticals to Present at the Roth 23rd Annual OC Growth Stock Conference

March 7, 2011 4:33 am | by Bio-Medicine.Org | Comments

CARLSBAD, Calif., March 7, 2011 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at Roth's 23rd Annual OC Growth Stock Conference on Monday, March 14, 2011 at 1:00 p.m. PT at the Ritz...

TOPICS:

CT Coronary Angiography Radiation Can Be Reduced While Maintaining Image Quality

March 7, 2011 4:32 am | by Diagnostic Imaging | Comments

Through carefully calculated adjustments to coronary imaging using dose-reduction techniques, cardiologists have managed to reduce the radiation delivered to patients undergoing coronary angiograms considerably. Plus, it's possible to maintain good image quality throughout, researchers found.

TOPICS:

Reducing CT Coronary Angiography Radiation, Maintaining Imaging Quality

March 7, 2011 4:32 am | by Diagnostic Imaging | Comments

Through carefully calculated adjustments to coronary imaging using dose-reduction techniques, cardiologists have managed to reduce the radiation delivered to patients undergoing coronary angiograms considerably. Plus, it's possible to maintain good image quality throughout, researchers found

TOPICS:

Toronto stock market heads for higher open, Mideast worries send oil past US$106

March 7, 2011 3:45 am | by Malcolm Morrison-Associated Press | Comments

The Toronto stock market could benefit from rising commodity stocks as crude oil prices push past the US$106 a barrel level while nervous investors seek safety moving gold prices higher.The Canadian benefitted from higher crude and bullion prices, rising 0.11 of a cent to 103.02 cents US.U.S....

PAREXEL Experts to Present Advanced Approaches to Accelerate Development, Maximize Product Value at DIA EuroMeeting

March 7, 2011 2:34 am | by Bio-Medicine.Org | Comments

BOSTON, March 7, 2011 /- Through various presentations to be delivered at the Drug Information Association (DIA) 23rd Annual EuroMeeting, being held March 28-30, 2011 in Geneva, Switzerland, experts from PAREXEL International Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical...

TOPICS:

Aerie Pharmaceuticals Completes $30 Million Series B Financing to Fund Further Development of Innovative Glaucoma Product Portfolio

March 7, 2011 2:34 am | by Bio-Medicine.Org | Comments

RESEARCH TRIANGLE PARK, N.C., March 7, 2011 /- Aerie Pharmaceuticals, Inc, a biotechnology company focused on the discovery and development of medical innovations in ophthalmology, today announced the closing of a $30 million Series B financing. Clarus Ventures and Sofinnova Ventures...

TOPICS:

Samplify Systems Completes Series B Funding

March 7, 2011 2:34 am | by Bio-Medicine.Org | Comments

SANTA CLARA, Calif., March 7, 2011 /- Samplify Systems, Inc., a leading provider of technology, semiconductors and sub-systems for medical, industrial, wireless, and scientific markets, has completed its Series B round of funding.  The $11.2M of capital enables the company to fund...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading